한글목차

액티브 휠체어 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 액티브 휠체어 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 5.8%를 기록할 것으로 추정되며, 2030년에는 23억 2,000만 달러에 달할 것으로 예측되고 있습니다.

노인 인구와 장애인 인구의 급증, 노인 인구의 만성 질환 유병률 증가가 시장 성장을 가속하는 주요 요인의 일부입니다.

노화는 일반적으로 자립 기능을 유지하기 위한 이동 능력과 신체적 작업 수행 능력을 저하시킵니다. 노인 인구 증가는 예측 기간 동안 액티브 휠체어 수요를 증가시킬 가능성이 높습니다. 또한 노인은 넘어지기 쉽고 치명적이거나 비치명적인 부상을 입을 수 있습니다. 서유럽은 고령자의 추락 관련 발생률과 사망률이 가장 높습니다. Injury Prevention이 발표한 조사 기사에 따르면 2017년에는 약 1,170만명의 노인이 부상으로 의료기관을 진찰했으며, 그중 840만명이 전도 관련 부상으로 인한 것이었습니다. 노인 증가와 노인의 추락 사고 증가는 예측 기간 동안 액티브 휠체어 수요를 촉진할 것으로 예측됩니다.

또한 기술적으로 진보된 액티브 휠체어의 도입은 사용자에게 편안함을 제공하기 때문에 시장을 견인할 것으로 예상됩니다. 또한 노인과 장애인을 돕기 위한 정부의 이니셔티브가 증가하고 있다는 점도 시장을 뒷받침하고 있습니다. 예를 들어, 미국 정부는 단기 및 장기 장애인을 위한 보험, 장애인을 위한 재정 지원 및 지원 서비스, 장애인을 위한 교육 및 고용 등 다양한 장애인을 위한 서비스를 국민에게 제공합니다. 2017년 인도 정부는 RashtriyaVayoshriYojana(RVY) 하에 이 나라의 저경제층에 속한 노인에게 노인 간호 지원 장비를 무료로 제공했습니다.

또한 액티브 휠체어 구매에 유리한 상환 정책, 사고 발생률 상승, 의료 인프라 지출 증가, 일상 생활 방식의 극적인 변화로 인한 세계 비만 인구 증가 등도 시장 성장을 가속할 것으로 예측됩니다.

액티브 휠체어 시장 : 분석 개요

• 수동 휠체어 분야는 장애 사례 증가, 주요 기업의 이니셔티브 증가, 기술 진보로 2024년에는 64.4% 이상의 최대 점유율을 차지했습니다.
• 전동 휠체어 부문은 예측 기간 동안 유리한 성장을 나타내는 것으로 보입니다. 장애 사례 증가와 기술의 진보가 시장 성장을 견인하고 있습니다.
• 뇌성 마비(CP) 분야는 2024년에 15.4%로 가장 큰 점유율을 차지했습니다. 뇌성 마비 환자 증가, 정부 이니셔티브 증가, 기술적으로 진보된 제품의 출시가 부문 성장의 원동력이 되고 있습니다.
• 북미의 액티브 휠체어 시장은 2024년 40.1%의 점유율을 차지했습니다. 이는 장애 발생률 증가, 고령화 사회의 이동성 솔루션에 대한 수요 증가, 정부 이니셔티브 증가로 인한 것입니다.
• 아시아태평양의 액티브 휠체어 시장은 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 장애인 증가, 알츠하이머병 환자 증가, 주요 기업의 전략적 이니셔티브, 정부의 이니셔티브 증가가 있습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 액티브 휠체어 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련/부수시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 액티브 휠체어 시장 : 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 액티브 휠체어 시장 : 유형별 추정과 동향 분석

• 액티브 휠체어 시장 : 유형별 대시보드
• 액티브 휠체어 시장 : 유형별 변동 분석
• 액티브 휠체어 시장 : 시장 규모 예측과 동향 분석, 유형별(2018-2030년)
• 수동 휠체어
• 전동 휠체어

제5장 액티브 휠체어 시장 : 적응증별 추정 및 동향 분석

• 액티브 휠체어 시장 : 적응증별 대시보드
• 액티브 휠체어 시장 : 적응증별 변동 분석
• 액티브 휠체어 시장 : 시장 규모 예측과 동향 분석, 적응증별(2018-2030년)
• 뇌성 마비
• 다발성 경화증
• 척수 손상
• 근이영양증
• 파킨슨병
• 이분척추
• 당뇨병
• 척추 측만증
• 알츠하이머병
• 근위축성 측삭 경화증(ALS)
• 기타

제6장 액티브 휠체어 시장 : 지역별 추정과 동향 분석(유형별, 적응증별, 지역별)

• 액티브 휠체어 시장 : 지역별 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 노르웨이
  • 덴마크
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 남아프리카
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 최신 동향과 영향 분석 : 주요 제조업체별
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 유통업체·채널 파트너 목록
  • 주요 고객
  • 주요 기업의 시장 점유율 분석(2024년)
  • Sunrise Medical
  • Numotion
  • MEYRA GmbH
  • Permobil
  • Invacare Corporation
  • Pride Mobility
  • Ottobock
  • Mountain Trike
  • Motion Composites

영문목차

Active Wheelchair Market Growth & Trends:

The global active wheelchair market size is expected to reach USD 2.32 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Surge in the geriatric and disabled population along with the rising prevalence of chronic diseases in the geriatric population are some of the key factors propelling the market growth.

Aging usually reduces the ability to move and perform physical tasks to maintain independent functioning. The increasing geriatric population is likely to create more demand for active wheelchairs over the forecast period. Moreover, they are more prone to falls, which can cause fatal or non-fatal injuries. The Western Europe region has the highest fall-related incidence and mortality rates in aged people. As per a research article published by Injury Prevention, in 2017, around 11.7 million aged people sought medical attention due to an injury, of which 8.4 million were owing to fall-related injuries. An increasing number of elderly people and rising incidents of falls in the elderly are projected to drive demand for active wheelchairs during the forecast period.

The introduction of technologically advanced active wheelchairs is also expected to drive the market as it provides more comfort to the users. In addition, increasing government initiatives to support the elderly and disabled population is boosting the market. For instance, the U.S. government provides various disability services to its citizens such as insurance for short-term and long-term disability, financial assistance & support services for the disabled, and education & jobs for persons with disabilities. In 2017, the Government of India offered free eldercare assistive devices under RashtriyaVayoshriYojana (RVY) to senior citizens belonging to lower economic strata of the country.

Furthermore, favorable reimbursement policies for the purchase of active wheelchairs, rising incidence of accidents, increasing spending on healthcare infrastructure, and increasing obese population across the globe due to drastic changes in daily lifestyle are also anticipated to propel the growth of the market.

Active Wheelchair Market Report Highlights:

• The manual wheelchair segment held the largest share of over 64.4% in 2024 due to the growing incidence of disability cases, rising initiatives by key companies, and technological advancements.
• The powered wheelchair segment will show lucrative growth during the forecast period. Increasing incidence of disability cases and technological advancements drive market growth.
• The cerebral palsy (CP) segment held the largest share at 15.4% in 2024. Increasing cerebral palsy cases, rising government initiatives, and technologically advanced product launches drive segment growth.
• North America active wheelchair market dominated with a share of 40.1% in 2024, owing to a rising incidence of disability, increasing demand for mobility solutions among the aging population, and increased government initiatives.
• The Asia Pacific active wheelchair market in is expected to grow fastest during the forecast period. There are increasing disability cases, rising cases of Alzheimer's disease, strategic initiatives by key players, and rising government initiatives.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Indication
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Segment
  • 2.2.2. Indication Segment
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Active Wheelchair Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of disability cases
    • 3.2.1.2. Growing road accident cases
    • 3.2.1.3. Increasing use of mobility devices
    • 3.2.1.4. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced products
• 3.3. Active Wheelchair Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Active Wheelchair Market: Type Estimates & Trend Analysis

• 4.1. Active Wheelchair Market: Type Dashboard
• 4.2. Active Wheelchair Market: Type Movement Analysis
• 4.3. Active Wheelchair Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Manual Wheelchair
  • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.5. Powered Wheelchair
  • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Active Wheelchair Market: Indication Estimates & Trend Analysis

• 5.1. Active Wheelchair Market: Indication Dashboard
• 5.2. Active Wheelchair Market: Indication Movement Analysis
• 5.3. Active Wheelchair Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Cerebral Palsy
  • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.5. Multiple Sclerosis
  • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.6. Spinal Cord Injury
  • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.7. Muscular Dystrophy
  • 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.8. Parkinson's Disease
  • 5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.9. Spina Bifida
  • 5.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.10. Diabetes
  • 5.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.11. Scoliosis
  • 5.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.12. Alzheimer's Disease
  • 5.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.13. Amyotrophic lateral sclerosis (ALS)
  • 5.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.14. Others
  • 5.14.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Active Wheelchair Market: Regional Estimates & Trend Analysis by Type, Indication, and Region

• 6.1. Global Active Wheelchair Market: Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Regulatory framework/ reimbursement structure
    • 6.3.4.3. Competitive scenario
    • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3. Japan
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.7. South Korea
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.3. South Africa
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Sunrise Medical
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Numotion
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. MEYRA GmbH
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Permobil
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Invacare Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Pride Mobility
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Ottobock
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Mountain Trike
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Motion Composites
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives